Infectious Diseases Special Edition: A Specialist Journal for the ID Community
Infectious Diseases Special Edition, known online as IDSE and found at idse.net, is a clinical publication for infectious disease specialists in the United States. Published in New York, New York, by McMahon Publishing, it appears six times a year as a journal-style print edition supported by a continuously updated website carrying news, review articles, conference coverage, monographs and continuing education links. Its readers are adult and pediatric infectious disease physicians and ID pharmacists — a small, highly specialised audience for whom antimicrobial resistance, HIV medicine, transplant infection, diagnostics and outbreak response are daily professional concerns.
Part of the McMahon Clinical Newspaper Family
IDSE belongs to McMahon Publishing, founded in 1972, whose clinical newspapers and journals serve some 300,000 clinicians across medical specialties and which the company says rank first in syndicated readership scores in their fields. Within the portfolio, IDSE sits alongside Clinical Oncology News, Pharmacy Practice News, Specialty Pharmacy Continuum, Gastroenterology and Endoscopy News, General Surgery News, Pain Medicine News and Anesthesiology News. McMahon's model is consistent across those titles: original reporting by specialist medical journalists, combined with conference coverage and contributions from practising experts, delivered free to qualified specialists in print and openly online. IDSE applies that model to infectious diseases, a specialty whose news cycle — outbreaks, guideline changes, new antimicrobials — moves faster than almost any other in medicine.
Audience and How Subscriptions Work
The print edition's circulation rules reveal the intended audience precisely. Practising United States physicians registered with the American Medical Association as infectious disease specialists, and United States pharmacists registered as ID pharmacists with the American Society of Health-System Pharmacists, may qualify to receive the print edition free, arranged through McMahon's circulation department; readers may also need to update their specialty designation with the AMA or ASHP to qualify. Those outside the qualified circulation can subscribe for 44 dollars a year in the United States or 54 dollars internationally. That controlled-circulation structure is typical of McMahon's titles and explains IDSE's editorial focus: every page assumes a reader who already manages complex infections professionally.
Editorial Structure and Sections
The website organises coverage into clinical sections that mirror the specialty's subdivisions: bacterial infections, fungal infection, HIV/AIDS, tropical diseases, pediatric infections, immunology and vaccination, diagnostics and technology, and policy and public health, alongside review articles, blogs, multimedia and regular features such as '5 Questions For…' interviews with figures in the field. A typical recent issue's archive shows the range in a single month: new IDSA guidelines for resistant gram-negative infections, expert selections from the MAD-ID and SIDP meetings, an interview on antifungal resistance, analysis of why antifungal failure is usually not resistance, rapid diagnostics and rapid antimicrobial susceptibility testing in an era of escalating resistance, long-acting HIV therapy maintaining suppression in patients with prior adherence challenges, and a feature on wastewater surveillance as the future of public health monitoring. Managing editor Meaghan Lee Callaghan leads the current editorial operation, with Joe Malichio serving as publication director and director of medical education.
Daily News on the Website
Between print issues, idse.net functions as a daily news service for the specialty. Recent headlines show its news judgement: a children's hospital stewardship programme that cut unnecessary expensive respiratory testing by 60 percent over twelve months, saving more than 500,000 dollars; GSK advancing an mRNA seasonal influenza vaccine candidate into phase 3 after positive phase 2 data; the Pan American Health Organization opening a pathway for fourteen Latin American and Caribbean countries to access lenacapavir for HIV prevention through its regional revolving funds; and a Legionnaires' disease case in an immunocompromised infant linked to a home formula preparation device. Each story is tagged to its clinical section, so the homepage reads as a running wire of the specialty's concerns — stewardship, vaccines, HIV prevention and unusual infection presentations alike.
Outbreak and Tropical Disease Coverage
IDSE maintains a dedicated tropical diseases desk, and its sustained coverage of the Bundibugyo virus disease outbreak in the Democratic Republic of Congo and Uganda demonstrates the depth it brings to emerging infections. Across 2026 its reporting followed the outbreak's suspected and confirmed case counts as they climbed past successive thresholds, the start of treatment trials, United States State Department response funding rising to 220 million dollars, revisions when the DRC health ministry ruled out many suspected cases, and assessments that the outbreak could rank among the largest Ebola disease events on record. Yellow fever transmission in the Americas received continuing attention in the same section. This is coverage aimed at specialists who may advise hospitals, health departments or travellers — reported as a developing clinical and public-health file, not as general news.
Monographs, Whitepapers and Special Reports
Beyond news, IDSE publishes monographs and whitepapers — long-form special reports, often produced with industry support, that examine a single therapeutic problem in depth. Recent examples include optimising treatment of difficult-to-treat gram-negative infections with cefiderocol, intravenous fosfomycin for complicated urinary tract infections, telavancin's role against MRSA persister cells, biofilms and persistent MRSA bacteremia, an annual antimicrobial efficacy reference folder, plasma microbial cell-free DNA metagenomic sequencing for infectious disease diagnosis, the global threat of typhoid fever, and the role of HIV testing and viral-load reporting in clinical practice. Free reprints are offered to readers. For practising specialists, these reports serve as focused updates on the resistant-organism and diagnostics questions that dominate ID consultation work.
Continuing Medical Education
Education is built into the IDSE platform. Its CME section connects readers to infectious disease continuing-education activities through CMEZone, including programmes such as herpes simplex virus infection in immunocompromised patients — covering presentation, diagnostics, treatment strategies, resistance and atypical presentations. That educational layer fits the McMahon pattern of combining news publishing with conferencing and medical-education services, and it reflects the audience's licensing reality: ID specialists must continuously document learning in a field where guidelines change with each resistance report and drug approval.
Conferences, Guidelines and the Stewardship Agenda
Three forces recur across IDSE's coverage. The first is the conference circuit — IDWeek, ESCMID Global and joint pharmacy-ID meetings — from which it files diagnostic digests and expert picks. The second is guideline movement, such as IDSA's updated guidance on resistant gram-negative infections, which it reports promptly because its readers prescribe against those documents. The third is antimicrobial stewardship: testing reduction, micafungin stewardship aided by beta-D-glucan assays in intensive care, and rapid susceptibility testing all appear as front-page concerns. Together they define the modern ID agenda IDSE chronicles — fewer unnecessary antimicrobials, faster identification of the organism, and better drugs for the infections that remain.
Advertising, Archives and Access
As a controlled-circulation trade journal, IDSE is supported by advertising, with annual media planners published for advertisers and classified and display sales handled through McMahon's team, including classified advertising manager Craig Wilson. Its online archive is searchable by issue, section and headline, giving the site a reference function beyond the current issue — a clinician can trace, for example, the full run of its Bundibugyo outbreak coverage or its diagnostics reporting across years. Print and digital reinforce each other: the website urges readers to read the full print edition and explains how non-subscribers can qualify or pay.
Place in Infectious Disease Media
Infectious disease clinicians can draw on society journals, government bulletins and general medical news, but IDSE occupies the trade-news layer of that ecosystem: faster than a journal, more specialised than a general medical newspaper, and written entirely for the ID workforce of physicians and pharmacists. Published by McMahon in New York, issued six times a year in print and updated daily at idse.net, Infectious Diseases Special Edition chronicles the specialty's defining struggles — resistant bacteria and fungi, HIV, emerging viruses, and the stewardship effort to preserve the drugs that still work — for the specialists charged with winning them.
